SEARCH

SEARCH BY CITATION

References

  • Andresen J. J., Faraci F. M. and Heistad D. D. (2004) Vasomotor responses in MnSOD-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 287, H1141H1148.
  • Austin S. A., Santhanam A. V. and Katusic Z. S. (2010) Endothelial nitric oxide modulates expression and processing of amyloid precursor protein. Circ. Res. 107, 14981502.
  • Brines M. and Cerami A. (2005) Emerging biological roles for erythropoietin in the nervous system. Nat. Rev. Neurosci. 6, 484494.
  • Brines M., Grasso G., Fiordaliso F. et al. (2004) Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc. Natl Acad. Sci. USA 101, 1490714912.
  • Buemi M., Lacquaniti A., Bolignano D., Cernaro V., Campo S., Grasso G., Buemi A., Donato V. and Sturiale A. (2009) Down with the erythropoietin. Long live the erythropoietin! Curr. Drug Targets 10, 10281032.
  • Chrissobolis S. and Faraci F. M. (2008) The role of oxidative stress and NADPH oxidase in cerebrovascular disease. Trends Mol. Med. 14, 495502.
  • Chrissobolis S., Miller A. A., Drummond G. R., Kemp-Harper B. K. and Sobey C. G. (2011) Oxidative stress and endothelial dysfunction in cerebrovascular disease. Front. Biosci. (Landmark Ed) 16, 17331745.
  • Digicaylioglu M. and Lipton S. A. (2001) Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412, 641647.
  • Erbayraktar S., Yilmaz O., Gokmen N. and Brines M. (2003) Erythropoietin is a multifunctional tissue-protective cytokine. Curr. Hematol. Rep. 2, 465470.
  • Faraci F. M. (2011) Protecting against vascular disease in brain. Am. J. Physiol. Heart Circ. Physiol. 300, H1566H1582.
  • Faraci F. M., Modrick M. L., Lynch C. M., Didion L. A., Fegan P. E. and Didion S. P. (2006) Selective cerebral vascular dysfunction in Mn-SOD-deficient mice. J. Appl. Physiol. (1985) 100, 20892093.
  • Genc K., Egrilmez M. Y. and Genc S. (2010) Erythropoietin induces nuclear translocation of Nrf2 and heme oxygenase-1 expression in SH-SY5Y cells. Cell Biochem. Funct. 28, 197201.
  • Ghezzi P., Bernaudin M., Bianchi R. et al. (2010) Erythropoietin: not just about erythropoiesis. Lancet 375, 2142.
  • Grasso G., Sfacteria A., Meli F., Passalacqua M., Fodale V., Buemi M., Giambartino F., Iacopino D. G. and Tomasello F. (2007) The role of erythropoietin in neuroprotection: therapeutic perspectives. Drug News Perspect. 20, 315320.
  • Itoh K., Chiba T., Takahashi S. et al. (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236, 313322.
  • Jin W., Wu J., Wang H., Kong J., Ni H. and Liang W. (2011) Erythropoietin administration modulates pulmonary Nrf2 signaling pathway after traumatic brain injury in mice. J. Trauma 71, 680686.
  • Jin W., Ming X., Hou X. et al. (2014) Protective effects of erythropoietin in traumatic spinal cord injury by inducing the Nrf2 signaling pathway activation. J. Trauma Acute Care Surg. 76, 12281234.
  • Katusic Z. S. and Austin S. A. (2013) Endothelial nitric oxide: protector of a healthy mind. Eur. Heart J. 35, 888894.
  • Khoo J. P., Nicoli T., Alp N. J., Fullerton J., Flint J. and Channon K. M. (2004) Congenic mapping and genotyping of the tetrahydrobiopterin-deficient hph-1 mouse. Mol. Genet. Metab. 82, 251254.
  • Kong X. J., Lee S. L., Lanzillo J. J. and Fanburg B. L. (1993) Cu, Zn superoxide dismutase in vascular cells: changes during cell cycling and exposure to hyperoxia. Am. J. Physiol. 264, L365L375.
  • Kops G. J., Dansen T. B., Polderman P. E. et al. (2002) Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419, 316321.
  • Lemasters J. J., Nieminen A. L., Qian T. et al. (1998) The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta 1366, 177196.
  • Ospina J. A., Krause D. N. and Duckles S. P. (2002) 17beta-estradiol increases rat cerebrovascular prostacyclin synthesis by elevating cyclooxygenase-1 and prostacyclin synthase. Stroke 33, 600605.
  • Park E. Y. and Rho H. M. (2002) The transcriptional activation of the human copper/zinc superoxide dismutase gene by 2,3,7,8-tetrachlorodibenzo-p-dioxin through two different regulator sites, the antioxidant responsive element and xenobiotic responsive element. Mol. Cell. Biochem. 240, 4755.
  • Park L., Anrather J., Forster C., Kazama K., Carlson G. A. and Iadecola C. (2004) Abeta-induced vascular oxidative stress and attenuation of functional hyperemia in mouse somatosensory cortex. J. Cereb. Blood Flow Metab. 24, 334342.
  • Rojo A. I., Salinas M., Martin D., Perona R. and Cuadrado A. (2004) Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-kappaB. J. Neurosci. 24, 73247334.
  • Santhanam A. V. and Katusic Z. S. (2006) Erythropoietin and cerebral vascular protection: role of nitric oxide. Acta Pharmacol. Sin. 27, 13891394.
  • Santhanam A. V., Smith L. A., Akiyama M., Rosales A. G., Bailey K. R. and Katusic Z. S. (2005) Role of endothelial NO synthase phosphorylation in cerebrovascular protective effect of recombinant erythropoietin during subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 36, 27312737.
  • Santhanam A. V., Smith L. A., Nath K. A. and Katusic Z. S. (2006) In vivo stimulatory effect of erythropoietin on endothelial nitric oxide synthase in cerebral arteries. Am. J. Physiol. Heart Circ. Physiol. 291, H781H786.
  • Santhanam A. V., d'Uscio L. V., He T. and Katusic Z. S. (2012a) PPARdelta agonist GW501516 prevents uncoupling of endothelial nitric oxide synthase in cerebral microvessels of hph-1 mice. Brain Res. 1483, 8995.
  • Santhanam A. V., d'Uscio L. V., Smith L. A. and Katusic Z. S. (2012b) Uncoupling of eNOS causes superoxide anion production and impairs NO signaling in the cerebral microvessels of hph-1 mice. J. Neurochem. 122, 12111218.
  • Schild L. and Reiser G. (2005) Oxidative stress is involved in the permeabilization of the inner membrane of brain mitochondria exposed to hypoxia/reoxygenation and low micromolar Ca2+. FEBS J. 272, 35933601.
  • Siren A. L., Fratelli M., Brines M. et al. (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl Acad. Sci. USA 98, 40444049.
  • d'Uscio L. V. and Katusic Z. S. (2008) Erythropoietin increases endothelial biosynthesis of tetrahydrobiopterin by activation of protein kinase B alpha/Akt1. Hypertension 52, 9399.
  • d'Uscio L. V., Milstien S., Richardson D., Smith L. and Katusic Z. S. (2003) Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity. Circ. Res. 92, 8895.
  • d'Uscio L. V., Smith L. A., Santhanam A. V., Richardson D., Nath K. A. and Katusic Z. S. (2007) Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin. Hypertension 49, 11421148.
  • d'Uscio L. V., Smith L. A. and Katusic Z. S. (2010) Erythropoietin increases expression and function of vascular copper- and zinc-containing superoxide dismutase. Hypertension 55, 9981004.
  • d'Uscio L. V., Smith L. A. and Katusic Z. S. (2011) Differential effects of eNOS uncoupling on conduit and small arteries in GTP-cyclohydrolase I-deficient hph-1 mice. Am. J. Physiol. Heart Circ. Physiol. 301, H2227H2234.
  • Vasquez-Vivar J., Martasek P., Whitsett J., Joseph J. and Kalyanaraman B. (2002) The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study. Biochem. J. 362, 733739.
  • Widlansky M. E. and Gutterman D. D. (2011) Regulation of endothelial function by mitochondrial reactive oxygen species. Antioxid. Redox Signal. 15, 15171530.
  • Zhang Q., Pi J., Woods C. G. and Andersen M. E. (2010) A systems biology perspective on Nrf2-mediated antioxidant response. Toxicol. Appl. Pharmacol. 244, 8497.
  • Zhang L., Zhang Z. G. and Chopp M. (2012) The neurovascular unit and combination treatment strategies for stroke. Trends Pharmacol. Sci. 33, 415422.